Can ‘Made in EU’ labels give European supplement brands an edge in China?
China’s nutraceutical market is expanding rapidly, with WPIC’s Peter McMath, Euromonitor’s Chloe Zhu, Barentz’s Alexandre Blanc, Hylobates Consulting’s Luca Bucchini, and PharmaLinea’s Matevž Ambrožič highlighting the importance of e-commerce growth, “Made in EU” trust, premium science-backed products, consumer localization, and regulatory preparation. The contributors emphasize that European brands can succeed in China by leveraging quality perception, innovative ingredients, digital channels, and tailored market strategies rather than simply exporting existing products.
Read the full article on the original site.
Read Full Article